COVID-19 vaccines: Current evidence and considerations

COVID-19 vaccines: Current evidence and considerations

The coronavirus disease 2019 (COVID-19) pandemic is a global crisis, with devastating health, business and social impacts. Vaccination is a safe, simple, and effective way of protecting a person against COVID-19. By the end of August 2021, only 24.6% of the world population has received two doses of...

Full description

Bibliographic Details
Main Authors:	Alireza Tavilani, Ebrahim Abbasi, PhD, Farhad Kian Ara, Ali Darini, Zahra Asefy, PhD
Format:	Article
Language:	English
Published:	Elsevier 2021-12-01
Series:	Metabolism Open
Subjects:	SARS-CoV-2 vaccine 2019-nCoV vaccines COVID-19 vaccines
Online Access:	http://www.sciencedirect.com/science/article/pii/S2589936821000487

Similar Items

Reported Adverse Effects and Attitudes among Arab Populations Following COVID-19 Vaccination: A Large-Scale Multinational Study Implementing Machine Learning Tools in Predicting Post-Vaccination Adverse Effects Based on Predisposing Factors
by: Ma’mon M. Hatmal, et al.
Published: (2022-02-01)

A review of neuro-ophthalmic sequelae following COVID-19 infection and vaccination
by: Jane Shi, et al.
Published: (2024-01-01)

Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses
by: Ning Wang, et al.
Published: (2020-02-01)

SARS-CoV-2 and Coronavirus Disease Mitigation: Treatment Options, Vaccinations and Variants
by: Almu’atasim Khamees, et al.
Published: (2022-02-01)

Glycans of SARS-CoV-2 Spike Protein in Virus Infection and Antibody Production
by: Xiaohui Zhao, et al.
Published: (2021-04-01)

Understanding COVID-19: From Dysregulated Immunity to Vaccination Status Quo
by: Ruby A. Escobedo, et al.
Published: (2021-11-01)

Nano‐therapeutic strategies to target coronavirus
by: Mohd Ahmar Rauf, et al.
Published: (2021-06-01)

Genomic Sequencing and Analysis of Eight Camel-Derived Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Isolates in Saudi Arabia
by: Badr M. Al-Shomrani, et al.
Published: (2020-06-01)

Understanding the challenges to COVID-19 vaccines and treatment options, herd immunity and probability of reinfection
by: Mohammad A.I. Al-Hatamleh, MSc, et al.
Published: (2023-06-01)

Safety and Adverse Events Related to COVID-19 mRNA Vaccines; a Systematic Review
by: SeyedAhmad SeyedAlinaghi, et al.
Published: (2022-05-01)

SARS-CoV-2 reinfection after previous infection and vaccine breakthrough infection through the second wave of pandemic in India: An observational study
by: Sachin Dhumal, et al.
Published: (2022-05-01)

Differential T-cell and antibody responses induced by mRNA versus adenoviral vectored COVID-19 vaccines in patients with immunodeficiencies
by: Ernest T. Aguinam, MPhil, et al.
Published: (2023-05-01)

Eosinophilic fasciitis following SARS-CoV-2 vaccination
by: Victoria Lobo Antuña, MD, et al.
Published: (2023-06-01)

Chronic spontaneous urticaria following COVID-19 vaccination
by: Laurence de Montjoye, MD, PhD, et al.
Published: (2022-07-01)

Comparing and Contrasting MERS, SARS-CoV, and SARS-CoV-2: Prevention, Transmission, Management, and Vaccine Development
by: Mohammad Oves, et al.
Published: (2020-11-01)

Is The SARS-CoV2 Evolved in Human Being: A prospective Genetic Analysis
by: Salvatore Dimonte, et al.
Published: (2020-12-01)

Insight into 2019 novel coronavirus — An updated interim review and lessons from SARS-CoV and MERS-CoV
by: Mingxuan Xie, et al.
Published: (2020-05-01)

The prevalence of COVID vaccine acceptance among pregnant women: A systematic review and meta-analysis
by: Kurvatteppa Halemani, et al.
Published: (2022-09-01)

Racial and ethnic disparities in COVID-19 booster vaccination among U.S. older adults differ by geographic region and Medicare enrollment
by: Kaleen N. Hayes, et al.
Published: (2023-08-01)

MERS Vaccine Candidate Offers Promise, but Questions Remain
by: Vineet D. Menachery
Published: (2015-10-01)

Strategies and safety considerations of booster vaccination in COVID-19
by: Hanyan Meng, et al.
Published: (2022-06-01)

Vaccines and Vaccination against SARS-CoV-2: Considerations for the Older Population
by: Birgit Weinberger
Published: (2021-12-01)

Global COVID-19 vaccine acceptance rate: Systematic review and meta-analysis
by: Dechasa Adare Mengistu, et al.
Published: (2022-12-01)

Effectiveness of the ChAdOx1 nCoV-19 Coronavirus Vaccine (Covishield<sup>TM</sup>) in Preventing SARS-CoV2 Infection, Chennai, Tamil Nadu, India, 2021
by: Sharan Murali, et al.
Published: (2022-06-01)

Challenges and future directions of potential natural products leads against 2019-nCoV outbreak
by: Meirambek Ospanov, et al.
Published: (2020-12-01)

Novel Coronavirus: Current Understanding of Clinical Features, Diagnosis, Pathogenesis, and Treatment Options
by: Mohammad Ridwane Mungroo, et al.
Published: (2020-04-01)

Current efforts and challenges facing responses to 2019-nCoV in Africa
by: Don Eliseo Lucero-Prisno, et al.
Published: (2020-05-01)

SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries
by: Hatem A. Elshabrawy
Published: (2020-06-01)

Determine the Potential Epitope Based Peptide Vaccine Against Novel SARS-CoV-2 Targeting Structural Proteins Using Immunoinformatics Approaches
by: Muhammad Waqas, et al.
Published: (2020-10-01)

Highly pathogenic coronaviruses: thrusting vaccine development in the spotlight
by: Chunting He, et al.
Published: (2020-07-01)

A Single Dose of ChAdOx1 nCoV-19 Vaccine Elicits High Antibody Responses in Individuals with Prior SARS-CoV-2 Infection Comparable to That of Two-Dose-Vaccinated, SARS-CoV-2-Infection-Naïve Individuals: A Longitudinal Study in Ethiopian Health Workers
by: Tesfaye Gelanew, et al.
Published: (2022-05-01)

SARS-CoV-2 Vaccine Effectiveness in Hospitalized Patients: A Multicenter Test-Negative Case–Control Study
by: Ireri Thirión-Romero, et al.
Published: (2023-11-01)

Major cardiac concerns in therapy and vaccinations for COVID-19
by: Syam Sundar Junapudi, MD, et al.
Published: (2021-09-01)

Pathophysiology of Vaccine-Induced Prothrombotic Immune Thrombocytopenia (VIPIT) and Vaccine-Induced Thrombocytopenic Thrombosis (VITT) and Their Diagnostic Approach in Emergency
by: Pierpaolo Di Micco, et al.
Published: (2021-09-01)

Allergy to COVID-19 vaccines: A current update
by: Beatriz Cabanillas, et al.
Published: (2021-07-01)

Associations of Temporal Cardiometabolic Patterns and Incident SARS-CoV-2 Infection Among U.S. Blood Donors With Serologic Evidence of Vaccination
by: Elaine A. Yu, PhD, et al.
Published: (2024-04-01)

Humoral Response Induced by Prime-Boost Vaccination with the ChAdOx1 nCoV-19 and mRNA BNT162b2 Vaccines in a Teriflunomide-Treated Multiple Sclerosis Patient
by: Yves Michiels, et al.
Published: (2021-10-01)

Broad and durable antibody response after vaccination with inactivated SARS-CoV-2 in individuals with a history of 2003 SARS-CoV infection
by: Huang Liang, et al.
Published: (2022-12-01)

Coronavirus vaccine development: from SARS and MERS to COVID-19
by: Yen-Der Li, et al.
Published: (2020-12-01)

Social Response to the Vaccine against COVID-19: The Underrated Power of Influence
by: Dimitra S. Mouliou, et al.
Published: (2021-12-01)